Sort
25,944 grants matching “neurodegeneration”
Development of S-PCT3010 to treat Parkinson's Disease
$847,789Thais Sielecki · Polycore Therapeutics, Llc · R44 · FY2020 · NS
Cell and Chemical Biology of Microtubules
$847,498Timothy J Mitchison · Harvard Medical School · R35 · FY2024 · GM
Cell and Chemical Biology of Microtubules
$847,498Timothy J Mitchison · Harvard Medical School · R35 · FY2025 · GM
Brain Effects of Lifetime Racial/Ethnic Discrimination on the LC-NE Function and the Risk for Alzheimer's Disease
$847,141Yu-Shin Ding · New York University School Of Medicine · R01 · FY2021 · AG
Understanding the protective and neuroinflammatory role of human brain immune cells in Alzheimer Disease
$847,139Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · AG
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population
$846,948Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R24 · FY2025 · OD
Genetic Drivers of Resilience to Alzheimer's Disease
$846,913Timothy J Hohman · Vanderbilt University Medical Center · R01 · FY2018 · AG
First in last out: how development informs neurodegeneration
$846,488Muriah D Wheelock · Washington University · R01 · FY2025 · AG
Wake-sleep Circuitry in Neurodegenerative Dementias
$846,397Clifford B Saper · Beth Israel Deaconess Medical Center · R01 · FY2025 · AG
Fluorescent biosensors for subcellular pharmacokinetics
$845,870Henry A. Lester · California Institute Of Technology · R01 · FY2016 · GM
Pathogenesis of Neurological Disability in Primary Diseases of Myelin
$845,598Bruce D Trapp · Cleveland Clinic Lerner Com-Cwru · R35 · FY2024 · NS
Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk
$844,972Craig C Weinkauf · University Of Arizona · R01 · FY2021 · AG
Noninvasive Low-cost Biomarkers for Preclinical Diagnosis and Longitudinal Tracking of Alzheimer's Disease Using Sleep and Resting State EEG
$844,721Patrick L. Purdon · Massachusetts General Hospital · R01 · FY2018 · AG
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$844,584Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AG
Contact System and Alzheimer's Disease: Mechanism and Therapeutic Potential
$844,508Sidney Strickland · Rockefeller University · R01 · FY2024 · NS
Contact System and Alzheimer's Disease: Mechanism and Therapeutic Potential
$844,508Sidney Strickland · Rockefeller University · R01 · FY2025 · NS
Transcriptional Control of Neuroinflammation in Alzheimer's Disease
$844,476Ming-Ming Zhou · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · AG
Integrated understanding of complex viral network biology in Alzheimer's Disease
$844,112Joel Thomas Dudley · Icahn School Of Medicine At Mount Sinai · R56 · FY2017 · AG
Testing miR-132 signaling and replacement as a common strategy for AD, FTD, and related pathologies
$843,850Anna M. Krichevsky · Brigham And Women'S Hospital · R56 · FY2020 · AG
RNA: Structure, Biophysics and Physiology
$843,703Adrian Ferrã-D'amarã · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Activated protein C mechanisms of brain white matter protection and new therapies for brain white matter ischemic injury
$843,669William J Mack · University Of Southern California · R01 · FY2022 · NS
Activated protein C mechanisms of brain white matter protection and new therapies for brain white matter ischemic injury
$843,669Berislav V Zlokovic · University Of Southern California · R01 · FY2021 · NS
Activated protein C mechanisms of brain white matter protection and new therapies for brain white matter ischemic injury
$843,669William J Mack · University Of Southern California · R01 · FY2024 · NS
Using geroscience to understand and treat Alzheimer's disease
$843,328Pamela Anne Maher · Salk Institute For Biological Studies · R01 · FY2020 · AG
Digital Neurodegenerative Pathology After Repetitive Head Impacts
$843,248Jesse Benjamin Mez · Boston University Medical Campus · R01 · FY2025 · NS